Centrally mediated disorders of gastrointestinal pain

Gastroenterology

Volumn 150, Issue 6, 2016, Pages 1408-1419

  Keefer, Laurie ^a   Drossman, Douglas A ^b   Guthrie, Elspeth ^c   Simrén, Magnus ^d   Tillisch, Kirsten ^e   Olden, Kevin ^f   Whorwell, Peter J ^g  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f SJHMC Internal Medicine Department   (United States)

^g WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Centrally Mediated Pain; Chronic Abdominal Pain; Functional Abdominal Pain; Narcotic Bowel; Rome IV

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; ANALGESIC ACTIVITY; ARTICLE; BRAIN REGION; CHRONIC PAIN; CLINICAL EVALUATION; DIGESTIVE SYSTEM FUNCTION DISORDER; DOCTOR PATIENT RELATION; DYSPEPSIA; GASTROINTESTINAL PAIN; HUMAN; HYPERALGESIA; IRRITABLE COLON; MEDICAL HISTORY; NEUROPATHIC PAIN; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

EID: 84964796111     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.02.034     Document Type: Article

References (79)

1. G.F. Longstreth, and J.F. Yao Irritable bowel syndrome and surgery: a multivariable analysis Gastroenterology 126 2004 1665 1673
2. J.J. Reimerink, M.J. van der Laan, M.J. Koelemay, and et al. Systematic review and meta-analysis of population-based mortality from ruptured abdominal aortic aneurysm Br J Surg 100 2013 1405 1413
3. R.E. Clouse, E.A. Mayer, Q. Aziz, and et al. Functional abdominal pain syndrome Gastroenterology 130 2006 1492 1497
4. D.A. Drossman, Z. Li, E. Andruzzi, and et al. US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact Dig Dis Sci 38 1993 1569 1580
5. W.G. Thompson, E.J. Irvine, P. Pare, and et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire Dig Dis Sci 47 2002 225 235
6. A.E. Bharucha, and M. Camilleri Functional abdominal pain in the elderly Gastroenterol Clin North Am 30 2001 517 529
7. N.A. Koloski, N.J. Talley, and P.M. Boyce Epidemiology and health care seeking in the functional GI disorders: a population-based study Am J Gastroenterol 97 2002 2290 2299
8. D.G. Maxton, and P.J. Whorwell Use of medical resorce and attitudes to health care of patients with chronic abdominal pain Br J Med Econ 2 1992 75 79
9. L. Van Oudenhove, J. Vandenberghe, P. Dupont, and et al. Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study Am J Gastroenterol 105 2010 913 924
10. M. Devor Neuropathic pain: what do we do with all these theories? Acta Anaesthesiol Scand 45 2001 1121 1127
11. A.D. Sperber, C.B. Morris, L. Greemberg, and et al. Development of abdominal pain and IBS following gynecological surgery: a prospective, controlled study Gastroenterology 134 2008 75 84
12. Z. Jiang, I.D. Dinov, J. Labus, and et al. Sex-related differences of cortical thickness in patients with chronic abdominal pain PLoS One 8 2013 e73932
13. J.S. Labus, I.D. Dinov, Z. Jiang, and et al. Irritable bowel syndrome in female patients is associated with alterations in structural brain networks Pain 155 2014 137 149
14. F. Zeng, W. Qin, Y. Yang, and et al. Regional brain structural abnormality in meal-related functional dyspepsia patients: a voxel-based morphometry study PLoS One 8 2013 e68383
15. E.A. Mayer, and S.M. Collins Evolving pathophysiologic models of functional gastrointestinal disorders Gastroenterology 122 2002 2032 2048
16. L. Van Oudenhove, J. Vandenberghe, P. Dupont, and et al. Regional brain activity in functional dyspepsia: a H(2)(15)O-PET study on the role of gastric sensitivity and abuse history Gastroenterology 139 2010 36 47
17. S.T. Wegener, R.C. Castillo, J. Haythornthwaite, and et al. Psychological distress mediates the effect of pain on function Pain 152 2011 1349 1357
18. D.A. Drossman Abuse, trauma, and GI illness: is there a link? Am J Gastroenterol 106 2011 14 25
19. L. Leung Pain catastrophizing: an updated review Indian J Psychol Med 34 2012 204 217
20. R. Esteve, and C. Ramirez-Maestre Pain fear avoidance and pain acceptance: a cross-sectional study comparing their influence on adjustment to chronic pain across three samples of patients Ann Behav Med 46 2013 169 180
21. D. Saunders Coping with chronic pain: what can we learn from pain self-efficacy beliefs? J Rheumatol 31 2004 1032 1034
22. L. Muller, H. Korsgaard, and S. Ethelberg Burden of acute gastrointestinal illness in Denmark 2009: a population-based telephone survey Epidemiol Infect 140 2012 290 298
23. L.M. McCracken, and C. Eccleston Coping or acceptance: what to do about chronic pain? Pain 105 2003 197 204
24. T. Yamada, J.M. Inadomi, R. Bhattacharya, and et al. Approach to the patient with abdominal pain T. Yamada, Yamada's Handbook of Gastroenterology 3rd ed. 2013 Wiley-Blackwell Philadelphia 58 69
25. D.A. Drossman Functional abdominal pain syndrome Clin Gastroenterol Hepatol 2 2004 353 365
26. D.A. Drossman Diagnosing and treating patients with refractory functional gastrointestinal disorders Ann Intern Med 123 1995 688 697
27. D.A. Drossman Patients with psychogenic abdominal pain: six years' observation in the medical setting Am J Psychiatry 139 1982 1549 1557
28. J. Leserman, D.A. Drossman, Z. Li, and et al. Sexual and physical abuse history in gastroenterology practice: how types of abuse impact health status Psychosom Med 58 1996 4 15
29. D.A. Drossman, J. Leserman, and J.B. Hu Gastrointestinal diagnosis, abuse history, and effects on health status Gastroenterology 111 1996 1159 1161
30. M. Grover, and D.A. Drossman Functional abdominal pain Curr Gastroenterol Rep 12 2010 391 398
31. S. Khan, and L. Chang Diagnosis and management of IBS Nat Rev Gastroenterol Hepatol 7 2010 565 581
32. S.J. Vanner, W.T. Depew, W.G. Paterson, and et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome Am J Gastroenterol 94 1999 2912 2917
33. A.D. Sperber, and D.A. Drossman Functional abdominal pain syndrome: Constant or frequently recurring abdominal pain Am J Gastoenterol 105 2010 770 774
34. W.D. Chey, B. Nojkov, J.H. Rubenstein, and et al. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial Am J Gastroenterol 105 2010 859 865
35. B.M. Spiegel, I.M. Gralnek, R. Bolus, and et al. Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome? Gastrointest Endosc 62 2005 892 899
36. D.A. Drossman 2012 David Sun Lecture: helping your patient by helping yourself: How to improve the patient-physician relationship by optimizing communication skills Am J Gastroenterol 2013 521 528
37. A.D. Sperber, and D.A. Drossman Review article: the functional abdominal pain syndrome Aliment Pharmacol Ther 33 2011 514 524
38. D.L. Roter, and J.A. Hall Doctors Talking With Patients/Patients Talking With Doctors: Improving Communication in Medical Visits 1992 Greenwood Publishing Group Westport, CT
39. D.A. Drossman Presidential address: gastrointestinal illness and biopsychosocial model Psychosom Med 60 1998 258 267
40. A.C. Ford, N.J. Talley, P.S. Schoenfeld, and et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis Gut 58 2009 367 378
41. D.A. Fishbain, R.B. Cutler, H.L. Rosomoff, and et al. Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder? A meta-analysis Psychosom.Med 60 1998 503 509
42. D.A. Drossman, B.B. Toner, W.E. Whitehead, and et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders Gastroenterology 125 2003 19 31
43. D.A. Drossman Beyond tricyclics: new ideas for treating patients with painful and refractory functional GI symptoms Am J Gastroenterol 104 2009 2897 2902
44. J.A. Mic, D. Ardid, E. Berrocoso, and et al. Antidepressants and pain Trends Pharmacol Sci 27 2006 348 354
45. A. Halpert, C.B. Dalton, N.E. Diamant, and et al. Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage Am J Gastroenterol 100 2005 664 671
46. L. Ruepert, A.O. Quartero, N.J. de Wit, and et al. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome Cochrane Database Syst Rev 2011 CD003460
47. S.F. Bomholt, J.D. Mikkelsen, and G. Blackburn-Munro Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain Neuropharmacology 48 2005 252 263
48. G.R. Locke, E.P. Bouras, C.W. Howden, and et al. The Functional Dyspepsia Treatment Trial (FDTT) key results Gastroenterology 144 2013 S140
49. P.J. Gaynor, M. Gopal, W. Zheng, and et al. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study Curr Med Res Opin 27 2011 1859 1867
50. S. Potvin, M. Morin, C. Cloutier, and et al. Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial J Clin Psychopharmacol 32 2012 684 687
51. D.A. Fishbain, R.B. Cutler, J. Lewis, and et al. Do the second-generation "atypical neuroleptics" have analgesic properties? A structured evidence-based review Pain Med 5 2004 359 365
52. M. Grover, S.D. Dorn, S.R. Weinland, and et al. Atypical antipsychotic Quetiapine in the management of severe, refractory functional gastrointestinal disorders Dig Dis Sci 54 2009 1284 1291
53. I.M. Aderka, C.P. McLean, J.D. Huppert, and et al. Fear, avoidance and physiological symptoms during cognitive-behavioral therapy for social anxiety disorder Behav Res Ther 51 2013 352 358
54. M.H. Trivedi, M. Fava, S.R. Wisniewski, and et al. Medication augmentation after the failure of SSRIs for depression N Engl J Med 354 2006 1243 1252
55. H. Rosoff, R.S. John, and F. Prager Flu, risks, and videotape: escalating fear and avoidance Risk Anal 32 2012 729 743
56. J.D. Gale, and L.A. Houghton Alpha 2 Delta (alpha(2)delta) ligands, gabapentin and pregabalin: what is the evidence for potential use of these ligands in irritable bowel syndrome Front Pharmacol 2 2011 28
57. L.A. Houghton, C. Fell, P.J. Whorwell, and et al. Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome Gut 56 2007 1218 1225
58. R.E. Harris, V. Napadow, J.P. Huggins, and et al. Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients Anesthesiol 119 2013 1453 1464
59. D.M.S. Grunkemeier, J.E. Cassara, C.B. Dalton, and et al. The narcotic bowel syndrome: clinical features, pathophysiology, and management Clin Gastroenterol Hepatol 5 2007 1126 1139
60. K. Goldapple, Z. Segal, C. Garson, and et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy Arch Gen Psychiatry 61 2004 34 41
61. M.B. Keller, J.P. McCullough, D.N. Klein, and et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression N Engl J Med 342 2000 1462 1470
62. K.A. Holroyd, F.J. O'Donnell, J. Stensland, and et al. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination JAMA 285 2001 2208 2215
63. R.P. Onders, and E.A. Mittendorf Utility of laparoscopy in chronic abdominal pain Surgery 134 2003 549 552 discussion 552-554
64. N. Di Lorenzo, G. Coscarella, F. Lirosi, and et al. [Impact of laparoscopic surgery in the treatment of chronic abdominal pain syndrome] Chir Ital 54 2002 367 378
65. D.A. Drossman, C.B. Morris, C.E. Wrennall, and et al. Diagnosis, characterization, and 3-month outcome after detoxification of 39 patients with narcotic bowel syndrome Am J Gastroenterol 107 2012 1426 1440
66. A.M. Trescot, M.V. Boswell, S.L. Atluri, and et al. Opioid guidelines in the management of chronic non-cancer pain Pain Physician 9 2006 1 39
67. A.D. Farmer, E. Ferdinand, and Q. Aziz Opioids and the gastrointestinal tract - a case of narcotic bowel syndrome and literature review J Neurogastroenterol Motil 19 2013 94 98
68. L.R. Watkins, E.D. Milligan, and S.F. Maier Glial activation: a driving force for pathological pain Trends Neurosci 24 2001 450 455
69. L.R. Watkins, M.R. Hutchinson, I.N. Johnston, and et al. Glia: novel counter-regulators of opioid analgesia Trends Neurosci 28 2005 661 669
70. M.R. Hutchinson, Y. Shavit, P.M. Grace, and et al. Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia Pharmacol Rev 63 2011 772 810
71. M.R. Hutchinson, L.C. Loram, Y. Zhang, and et al. Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity Neuroscience 168 2010 551 563
72. S.M. Crain, and K.F. Shen Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability Pain 84 2000 121 131
73. F. Porreca, M.H. Ossipov, and G.F. Gebhart Chronic pain and medullary descending facilitation Trends Neurosci 25 2002 319 325
74. H.L. Fields Is there a facilitating component to central pain modulation? Am Pain Soc J 1 1992 71 78
75. S. Agostini, H. Eutamene, C. Cartier, and et al. Evidence of central and peripheral sensitization in a rat model of narcotic bowel like-syndrome Gastroenterology 139 2010 553 563
76. M. Brabant, S. Brissette, P. Lauzon, and et al. [Opioid use disorder in patients with chronic non-cancer pain] Sante Ment Que 39 2014 117 132
77. D.S. Hasin, C.P. O'Brien, M. Auriacombe, and et al. DSM-5 criteria for substance use disorders: recommendations and rationale Am J Psychiatry 170 2013 834 851
78. R. Dekel, D.A. Drossman, and A.D. Sperber The use of psychotropic drugs in irritable bowel syndrome Expert Opin Investig Drugs 22 2013 329 339
79. S.F. Butler, S.H. Budman, K.C. Fernandez, and et al. Development and validation of the Current Opioid Misuse Measure Pain 130 2007 144 156